Safety, Tolerability, Pharmacokinetics and Efficacy of ARCO
NCT01930331
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Plasmodium Falciparum
Malaria, Falciparum
Interventions
DRUG:
artemisinin/naphthoquine
DRUG:
dihydroartemisinin/piperaquine phosphate
Sponsor
Ifakara Health Institute